Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-109,153
Closed -$217K 1762
2025
Q2
$217K Buy
+109,153
New +$200K 0.01% 1445

Y-Intercept (HK)'s HLVX Position: Q3 2025 in Review

Y-Intercept (HK) sold out of HilleVax (HLVX) in Q3 2025, closing a stake of 109,153 shares — an estimated $217K sold.

Y-Intercept (HK) first reported a position in HLVX in Q2 2025 and held it in 1 quarter. The position peaked at $217K in Q2 2025. 1 fund tracked by Wall St. Rank holds HLVX as of Q3 2025.

  • Y-Intercept (HK) reported no remaining HilleVax position as of Q3 2025 after selling out during the quarter.
  • Y-Intercept (HK) sold 109,153 HilleVax shares in Q3 2025, an estimated $217K.
  • Y-Intercept (HK) first reported a position in HilleVax in Q2 2025 and held it in 1 quarter.
  • Y-Intercept (HK)'s HilleVax position peaked at $217K in Q2 2025.
  • 1 fund tracked by Wall St. Rank held HilleVax as of Q3 2025.

Based on Y-Intercept (HK)'s 13F filing for Q3 2025, filed 31 Oct 2025.